WP2: Development of 3D printed devices and formulations

The main aim of WP2 will be to design, prepare and characterize new formulations with antimicrobial functionality. For developing these, printing technologies will be exploited. New formulations will be directly applied to counteract BRIs in medical devices. Proof-of-concept endotracheal catheters and femur implants will be fabricated with 3D-printing incorporated antimicrobials. Alternatively, bioprinting will be utilized to coat 3D- printed devices. Based on in vitro functionality studies, the best candidate formulations will be chosen for WP3.